000 01725 a2200493 4500
005 20250516031910.0
264 0 _c20110617
008 201106s 0 0 eng d
022 _a1097-0045
024 7 _a10.1002/pros.21298
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGonzalez-Moreno, Oscar
245 0 0 _aSelenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage.
_h[electronic resource]
260 _bThe Prostate
_cJun 2011
300 _a824-34 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAndrogen Antagonists
_xpharmacology
650 0 4 _aCarcinoma
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Transformation, Neoplastic
_xmetabolism
650 0 4 _aDown-Regulation
650 0 4 _aFlutamide
_xpharmacology
650 0 4 _aHumans
650 0 4 _aHydrogen Peroxide
_xtoxicity
650 0 4 _aMale
650 0 4 _aOxidative Stress
650 0 4 _aProstatic Intraepithelial Neoplasia
_xmetabolism
650 0 4 _aProstatic Neoplasms
_xmetabolism
650 0 4 _aRNA, Small Interfering
_xmetabolism
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aSelenoprotein P
_xantagonists & inhibitors
700 1 _aBoque, Noemi
700 1 _aRedrado, Miriam
700 1 _aMilagro, Fermin
700 1 _aCampion, Javier
700 1 _aEndermann, Tobias
700 1 _aTakahashi, Kazuhiko
700 1 _aSaito, Yoshiro
700 1 _aCatena, Raul
700 1 _aSchomburg, Lutz
700 1 _aCalvo, Alfonso
773 0 _tThe Prostate
_gvol. 71
_gno. 8
_gp. 824-34
856 4 0 _uhttps://doi.org/10.1002/pros.21298
_zAvailable from publisher's website
999 _c20724484
_d20724484